Identification and validation of STEAP3 as a ferroptosis-related biomarker in heart failure
-
By
-
Huijuan Chen
-
Lingqi Xu
-
June 1, 2026
-
Clinical Scorecard: Discovery and validation of STEAP3 as a biomarker associated with ferroptosis in heart failure
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | Aging-related programmed cell death (PCD), ferroptosis, autophagy, necroptosis - ensure these are linked to study findings. |
| Target Population | |
| Care Setting | |
Key Highlights
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
- I
- n
- c
- l
- u
- d
- e
-
- s
- p
- e
- c
- i
- f
- i
- c
-
- b
- i
- o
- m
- a
- r
- k
- e
- r
- s
-
- f
- o
- r
-
- m
- o
- n
- i
- t
- o
- r
- i
- n
- g
-
- f
- e
- r
- r
- o
- p
- t
- o
- s
- i
- s
- .
Risks
Patient & Prescribing Data
Add potential side effects of beta-blockers and diuretics.
Clinical Best Practices
Related Resources & Content
